These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 34684874)

  • 21. Increasing outer membrane complexity: the case of the lipopolysaccharide lipid A from marine Cellulophaga pacifica.
    Andretta E; De Chiara S; Pagliuca C; Cirella R; Scaglione E; Di Rosario M; Kokoulin MS; Nedashkovskaya OI; Silipo A; Salvatore P; Molinaro A; Di Lorenzo F
    Glycoconj J; 2024 Apr; 41(2):119-131. PubMed ID: 38642279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bacterial endotoxins: relationship between chemical structure and biological effect].
    Rietschel ET; Brade L; Schade FU; Seydel U; Zähringer U; Mamat U; Schmidt G; Ulmer AJ; Loppnow H; Flad HD
    Immun Infekt; 1993 Apr; 21(2):26-35. PubMed ID: 8340135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tailored Modulation of Cellular Pro-inflammatory Responses With Disaccharide Lipid A Mimetics.
    Heine H; Adanitsch F; Peternelj TT; Haegman M; Kasper C; Ittig S; Beyaert R; Jerala R; Zamyatina A
    Front Immunol; 2021; 12():631797. PubMed ID: 33815382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid A, the immunostimulatory principle of lipopolysaccharides?
    Loppnow H; Dürrbaum I; Brade H; Dinarello CA; Kusumoto S; Rietschel ET; Flad HD
    Adv Exp Med Biol; 1990; 256():561-6. PubMed ID: 2327301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular adjuvants and immunomodulators: new approaches to immunization.
    Johnson AG
    Clin Microbiol Rev; 1994 Jul; 7(3):277-89. PubMed ID: 7923049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Taking toll: lipid A mimetics as adjuvants and immunomodulators.
    Persing DH; Coler RN; Lacy MJ; Johnson DA; Baldridge JR; Hershberg RM; Reed SG
    Trends Microbiol; 2002; 10(10 Suppl):S32-7. PubMed ID: 12377566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunomodulation of C3H/HeJ cells by endotoxin associated protein and lipopolysaccharide endotoxin.
    Sultzer BM; Bandekar J; Castagna R; Abu-Lawi K
    Adv Exp Med Biol; 1992; 319():39-48. PubMed ID: 1414604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel class of endotoxin receptor agonists with simplified structure, toll-like receptor 4-dependent immunostimulatory action, and adjuvant activity.
    Hawkins LD; Ishizaka ST; McGuinness P; Zhang H; Gavin W; DeCosta B; Meng Z; Yang H; Mullarkey M; Young DW; Yang H; Rossignol DP; Nault A; Rose J; Przetak M; Chow JC; Gusovsky F
    J Pharmacol Exp Ther; 2002 Feb; 300(2):655-61. PubMed ID: 11805229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunopharmacology of lipid A mimetics.
    Bowen WS; Gandhapudi SK; Kolb JP; Mitchell TC
    Adv Pharmacol; 2013; 66():81-128. PubMed ID: 23433456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The low-toxicity versions of LPS, MPL adjuvant and RC529, are efficient adjuvants for CD4+ T cells.
    Thompson BS; Chilton PM; Ward JR; Evans JT; Mitchell TC
    J Leukoc Biol; 2005 Dec; 78(6):1273-80. PubMed ID: 16204643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving the immunostimulatory potency of diethanolamine-containing lipid A mimics.
    Lewicky JD; Ulanova M; Jiang ZH
    Bioorg Med Chem; 2013 Apr; 21(8):2199-2209. PubMed ID: 23490149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pushing the envelope: LPS modifications and their consequences.
    Simpson BW; Trent MS
    Nat Rev Microbiol; 2019 Jul; 17(7):403-416. PubMed ID: 31142822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunomodulation by bacterial endotoxin.
    Burrell R
    Crit Rev Microbiol; 1990; 17(3):189-208. PubMed ID: 1689164
    [No Abstract]   [Full Text] [Related]  

  • 34. Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity.
    van der Ley P; Steeghs L; Hamstra HJ; ten Hove J; Zomer B; van Alphen L
    Infect Immun; 2001 Oct; 69(10):5981-90. PubMed ID: 11553534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic vaccines: the role of adjuvants in immune targeting.
    Jiang ZH; Koganty RR
    Curr Med Chem; 2003 Aug; 10(15):1423-39. PubMed ID: 12871139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rhizobium sin-1 lipopolysaccharide (LPS) prevents enteric LPS-induced cytokine production.
    Vandenplas ML; Carlson RW; Jeyaretnam BS; McNeill B; Barton MH; Norton N; Murray TF; Moore JN
    J Biol Chem; 2002 Nov; 277(44):41811-6. PubMed ID: 12193596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Lipid A from Rhodopseudomonas palustris Strain BisA53 LPS Possesses a Unique Structure and Low Immunostimulant Properties.
    Di Lorenzo F; Palmigiano A; Al Bitar-Nehme S; Sturiale L; Duda KA; Gully D; Lanzetta R; Giraud E; Garozzo D; Bernardini ML; Molinaro A; Silipo A
    Chemistry; 2017 Mar; 23(15):3637-3647. PubMed ID: 28004420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of a nontoxic monophosphoryl lipid A.
    Johnson AG; Tomai M; Solem L; Beck L; Ribi E
    Rev Infect Dis; 1987; 9 Suppl 5():S512-6. PubMed ID: 3317747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation into the interaction of recombinant human serum albumin with Re-lipopolysaccharide and lipid A.
    Jürgens G; Müller M; Garidel P; Koch MH; Nakakubo H; Blume A; Brandenburg K
    J Endotoxin Res; 2002; 8(2):115-26. PubMed ID: 12028751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial lipopolysaccharides and innate immunity.
    Alexander C; Rietschel ET
    J Endotoxin Res; 2001; 7(3):167-202. PubMed ID: 11581570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.